R&D costs of Novo Nordisk 2018-2023
In 2023, Danish pharmaceutical company Novo Nordisk spent more than 32 billion kroner on research and development. This corresponded to some 14 percent of the company's total sales. Since 2020, Novo Nordisk's R&D costs have more than doubled.